Form D — Rila Therapeutics, Inc.
0002051051-25-000001 · filed 2025-01-07
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $10,759,378
- Total sold
- $6,978,195
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Rila Therapeutics, Inc.
- CIK
- 2051051
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 280 UTAH AVENUE
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 650-410-5000
Related persons
-
Robert Drakas · Executive OfficerSouth San Francisco, CA
-
William Dai · DirectorSouth San Francisco, CA
-
Michael Hui · DirectorSouth San Francisco, CA
View original on SEC EDGAR.